No.

Publication Date

Citing Article

1

2025

Anna Di Spirito, Sahar Balkhi, Veronica Vivona, Lorenzo Mortara. Key immune cells and their crosstalk in the tumor microenvironment of bladder cancer: insights for innovative therapies, Exploration of Targeted Anti-tumor Therapy. 2025; 6: 1002304.  https://doi.org/10.37349/etat.2025.1002304

2

2023

Natasa Kustrimovic, Raffaella Bombelli, Denisa Baci, Lorenzo Mortara. Microbiome and Prostate Cancer: A Novel Target for Prevention and Treatment, International Journal of Molecular Sciences. 2023; 24: 1511.  https://doi.org/10.3390/ijms24021511

3

2025

Mingfeng Li, Louis Boafo Kwantwi, Cuimei Wang, Qin Xiao. Tumor microenvironment-mediated immune evasion and resistance in prostate cancer: mechanisms, cross-talk, and therapeutic opportunities, Clinical and Experimental Medicine. 2025; 26: 60.  https://doi.org/10.1007/s10238-025-01944-0

4

2025

Akram Hoseinzadeh, Seyed-Alireza Esmaeili, Reza Sahebi, Anahita Madani Melak, Mahmoud Mahmoudi, Maliheh Hasannia, Rasoul Baharlou. Fate and long-lasting therapeutic effects of mesenchymal stromal/stem-like cells: mechanistic insights, Stem Cell Research & Therapy. 2025; 16: 33.  https://doi.org/10.1186/s13287-025-04158-z

5

2025

Roberto Rosenfeld, Stefano Sganga, Marco Badalamenti, Sveva Mortellaro, Marta Scorsetti, Ornella Garrone, Giovanni Maria Iannantuono, Elias Chandran, Michele Ghidini, Ciro Franzese. Combinations of treatments based on radiotherapy or radionuclides to enhance immunotherapy efficacy in advanced prostate cancer: a systematic review, Journal of Cancer Research and Clinical Oncology. 2025; 151: 195.  https://doi.org/10.1007/s00432-025-06245-3

6

2026

Jie Xu, Ruimin Hu, Jun Zheng, Qian Ju, Youxin Liu, Saipeng Chen, Zhicheng Liu, Yuhao Lei, Jing Yang, Dinglin Zhang, Wenhao Shen. Modulation of the intestinal microbiome and reversal of the immunosuppressive microenvironment by nanoparticles for chemoimmunotherapy in prostate cancer, Journal of Advanced Research. 2026;   https://doi.org/10.1016/j.jare.2026.02.027

7

2026

Marzia Di Donato, Pia Giovannelli, Marco De Sio, Antimo Migliaccio, Gabriella Castoria. NGF-mediated tumor–stroma crosstalk promotes prostate cancer aggressiveness, Journal of Translational Medicine. 2026; 24: 356.  https://doi.org/10.1186/s12967-026-07915-7

8

2025

Vikrant Rai, Immune Checkpoint Inhibitor Therapy for Prostate Cancer: Present and Future Prospectives, Biomolecules. 2025; 15: 751.  https://doi.org/10.3390/biom15060751

9

2024

Margarita Zvirble, Zilvinas Survila, Paulius Bosas, Neringa Dobrovolskiene, Agata Mlynska, Gintaras Zaleskis, Jurgita Jursenaite, Dainius Characiejus, Vita Pasukoniene. Prognostic significance of soluble PD-L1 in prostate cancer, Frontiers in Immunology. 2024; 15: 1401097.  https://doi.org/10.3389/fimmu.2024.1401097

10

2025

Duo Zhang, Yu Heng, Qiu-yan Jin, Di Tang, Xiao-ke Zhu, Li-ming Lu, Chun-ping Wu, Lei Tao. Prognostic significance of cytotoxic-T-lymphocytes to immunosuppressive lymphocytes ratio (CIL) in laryngeal squamous cell carcinoma, Cancer Immunology, Immunotherapy. 2025; 74: 157.  https://doi.org/10.1007/s00262-025-04008-0

11

2023

Feixiang Yang, Jiawei Li, Qintao Ge, Yuchen Zhang, Meng Zhang, Jun Zhou, Haitao Wang, Juan Du, Shenglin Gao, Chaozhao Liang, Jialin Meng. Non-coding RNAs: Emerging roles in the characterization of immune microenvironment and immunotherapy of prostate cancer, Biochemical Pharmacology. 2023; 214: 115669115669.  https://doi.org/10.1016/j.bcp.2023.115669

12

2025

Ngan Nguyen, Ian C. Henrich. Intra- and Extrahepatic Cholangiocarcinomas Display Differing Sensitivities to NK Cell Lysis and Modulate NK Cell Function through Shared and Distinct Pathways, Molecular Cancer Research. 2025; 23: 155.  https://doi.org/10.1158/1541-7786.MCR-24-0299

13

2025

Whi-An Kwon, Jae Young Joung. Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers, Biomolecules. 2025; 15: 625.  https://doi.org/10.3390/biom15050625

14

2025

Kadriia I. Enikeeva, Diana Kh. Gainullina, Polina N. Shmelkova, Yuliya V. Sharifyanova, Elina R. Akramova, Ildar R. Kabirov, Valentin N. Pavlov. Reprogramming the immune response in prostate cancer treatment, Urology reports (St. - Petersburg). 2025; 15: 75.  https://doi.org/10.17816/uroved646326

15

2023

O. A. Korovin, A. V. Alyasova, Kh. M. Arioua, D. V. Novikov, N. V. Krasnogorova, V. V. Novikov. Analysis of the IL-10 mRNA level in the peripheral blood of patients with cancer and benign prostatic hyperplasia, Russian Journal of Biotherapy. 2023; 22: 35.  https://doi.org/10.17650/1726-9784-2023-22-4-35-42

16

2026

Munendra Singh Tomar, Komal Raina, Neha Mishra, Rama Kant, Jennifer T. Fox, Chapla Agarwal, Rajesh Agarwal. Distinct Tumor Infiltrating Immune Cell Profiles in Mice by Non‐Steroidal Anti‐Inflammatory Drugs (Aspirin and Naproxen) During TMPRSS2‐ERG (Fusion)‐Driven and Non‐Fusion Driven Prostate Cancer, Molecular Carcinogenesis. 2026; mc.70099.  https://doi.org/10.1002/mc.70099

17

2024

Sandra C. Ordonez-Rubiano, Brayden P. Strohmier, Surbhi Sood, Emily C. Dykhuizen. SWI/SNF chromatin remodelers in prostate cancer progression, Frontiers in Epigenetics and Epigenomics. 2024; 1: 1337345.  https://doi.org/10.3389/freae.2023.1337345

18

2025

Malin Hagberg Thulin, Håkon Ramberg, Heidi Kristin Nielsen, Helene Hartvedt Grytli, Shivanthe Sivanesan, Abhilash D. Pandya, Kotryna Seip, Kjetil Wessel Andressen, Anna Linder, Miriam Øijordsbakken, Matti Poutanen, Betina Katz, Bente Halvorsen, Gunhild Mari Mælandsmo, Kristin Austlid Taskén. Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis, Journal of Translational Medicine. 2025; 23: 672.  https://doi.org/10.1186/s12967-025-06644-7